0.01 (0.926%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Strong
Earnings
Very Strong
Dividends
Very Weak
Capital Efficiency
Neutral
Balance Sheet
Very Weak
Website
BioXcel Therapeutics, Inc.
Telephone
1.475.238.6837
Address
12th floor, 555 Long Wharf Drive, New Haven, CT 06511
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.01 - 8.08
Trade Value (12mth)
US$2,564,615.00
1 week
-5.26%
1 month
-6.09%
YTD
-36.47%
1 year
-22.3%
All time high
1144.00
EPS 3 yr Growth
-94.00%
EBITDA Margin
NaN%
Operating Cashflow
-$58m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-2.90
Quick Ratio
0.80
Shares Outstanding (Fully Diluted)
24m
HALO Sector
Healthcare
Next Company Report Date
11-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 15 May 26 | |
| 15 May 26 | |
| 15 May 26 | |
| 15 May 26 | |
| 18 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -98.35 | -23.51 | -5.73 | | | | ||
EPS (Fully Diluted) | $ | | | | | -98.35 | -23.51 | -5.73 | | | | ||
Growth | % | | | | | -3.9 | 76.1 | 75.6 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
